Moderate Renal Impairment (CrCl 30-50 mL/Min)
1 clinical trials · Condition
◉ Watch Moderate Renal Impairment (CrCl 30-50 mL/Min)
| Record | Firm | Date |
|---|---|---|
| Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate (NCT01184989) | Boehringer Ingelheim | 2010-08-01 |
Track Moderate Renal Impairment (CrCl 30-50 mL/Min) automatically
Every clearance here is in the API, with alerts when new ones post.